Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Live from ASH 2022 | Ascentage Pharma Presents Latest Data of APG-2575, Including Encouraging Results of the Combination with BTKi in Patients with R/R CLL/SLL 2022-12-13 17:39
CARsgen Presents Data from China Pivotal Phase II Trial of BCMA CAR T Zevor-cel (CT053) at 2022 ASH Annual Meeting 2022-12-12 21:50
PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab) 2022-12-12 21:00
Asieris'Bladder Cancer Diagnostic Drug Hexvix® Completed Dosing of First Patient in Real-World Clinical Study 2022-12-12 20:59
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery 2022-12-12 10:10
Gracell Biotechnologies Presents Clinical Data for FasTCAR-T GC012F for High Risk, Newly Diagnosed Multiple Myeloma Demonstrating 100% Overall Response Rate 2022-12-11 07:15
Shenzhen Holds 2022 Global Investment Promotion Conference to Build a Magnet for International Investors 2022-12-09 11:16
SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France 2022-12-09 06:30
ReviR Therapeutics to Present at RNA Targeted Drug Discovery Summit 2022-12-08 23:00
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA 2022-12-08 22:00
PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023 during JPM Week 2022-12-08 21:00
CABIO Showcases the Latest Research Results and Innovative Solutions at Food Ingredients Europe 2022 2022-12-08 21:00
Createrna Announces Positive Top-Line Results from Phase 1 Clinical Trials of QR052107B Tablet in Healthy Volunteers 2022-12-08 14:29
Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022 2022-12-06 21:04
Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF) 2022-12-06 21:01
Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030 2022-12-06 20:00
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp 2022-12-05 20:00
The First IBCC Unveiled in Hainan 2022-12-05 15:55
Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022 2022-12-05 08:00
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-12-03 05:10
1 65 66 67 68 69 222